UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma
Public ClinicalTrials.gov record NCT04382664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of UV1 Vaccination in Combination With Nivolumab and Ipilimumab as First Line Treatment of Patients With Unresectable or Metastatic Melanoma (INITIUM Study)
Study identification
- NCT ID
- NCT04382664
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ultimovacs ASA
- Industry
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Interventions
- Ipilimumab Biological
- Nivolumab Biological
- Sargramostim Biological
- UV1 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 26, 2020
- Primary completion
- Jan 10, 2024
- Completion
- Apr 9, 2024
- Last update posted
- Jan 13, 2025
2020 – 2024
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Hospital | Phoenix | Arizona | 85016-4880 | — |
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| University of California Irvine Health | Orange | California | 92868 | — |
| California Cancer Associates for Research & Excellence (CCARE | San Marcos | California | 92083 | — |
| Ridley-Tree Cancer Center | Santa Barbara | California | 93105 | — |
| Saint John's Health Center - John Wayne Cancer Institute (JWCI) | Santa Monica | California | 90404 | — |
| University of Colorado Hospital - Anschutz Cancer Pavilion | Aurora | Colorado | 80045 | — |
| Holy Cross Medical Group | Fort Lauderdale | Florida | 33308 | — |
| Sylvester Comprehensive Cancer Center | Miami | Florida | 33136-1002 | — |
| Ocala Oncology Center | Ocala | Florida | 34474 | — |
| Rush University Medical Center - Rush University Cancer Center | Chicago | Illinois | 60612-3841 | — |
| NorthShore University Research Institute | Evanston | Illinois | 60201-1718 | — |
| Oncology Specialists, S.C. | Park Ridge | Illinois | 60068 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40241 | — |
| Nebraska Cancer Specialists- Midwest Cancer Center | Papillion | Nebraska | 68046-5706 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| State University of New York (SUNY) Upstate Medical University | New York | New York | 13210 | — |
| University of Rochester | Rochester | New York | 14642-0001 | — |
| NorthShore University HealthSystem | Greenville | South Carolina | 29607 | — |
| Texas Oncology - Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246-2092 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04382664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2025 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04382664 live on ClinicalTrials.gov.